Back to all studies
RecruitingACTRN12622000909729

Efficacy of Theta Burst Transcranial Magnetic Stimulation for Premenstrual Dysphoric Disorder – An Open Label Study

The registry lists this study as recruiting. Study locations are listed in Australia. Confirm recruitment at each site. It focuses on Premenstrual Dysphoric Disorder.

Mental health, Premenstrual Dysphoric DisorderDeviceFrom 18 Years to 45 Years
In plain English

Key information made simple

What the source says

The registry describes this research topic: “Transcranial Magnetic Stimulation (TMS) to Treat Premenstrual Dysphoric Disorder”. This is an interventional study. The registry lists a target sample size of 30. Recruitment status at the registry update of 2024-01-16: recruiting. Read the original description and eligibility criteria, and confirm the practical details with the study team.

What should you check before joining?

Check the full criteria in the official source. Ask the team to confirm recruitment, locations, visits, risks and participation requirements.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNovember 25, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
Monash University
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not ApplicableFormal phases are mostly used for medication studies and some device studies. Some studies do not use a phase.
Locations
Australia
Age range
From 18 Years to 45 Years
Official registry ID
ACTRN12622000909729
Official title
Efficacy of Theta Burst Transcranial Magnetic Stimulation for the Treatment of Premenstrual Dysphoric Disorder – An Open Label Pilot Study

Want help reviewing this study?

Loading the security check...
Study ID: ACTRN12622000909729. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Australia · 1 site
  • Monash Alfred Psychiatry Research Centre
    Melbourne
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring brain stimulation for people with mental health. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The listed phase is Not Applicable. Ask the study team what that means in practice for safety, monitoring, and criteria.

Who might this study be for?

This study may concern people with mental health; age range: From 18 Years to 45 Years. The criteria appear strict, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Monash University, which appears to be a university. The listed contact or investigator is Elizabeth Thomas. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me